Lexaria Bioscience Corp. (LEXX): Total Liabilities
$1.57M
As of 2025-08-31
$437.1K
As of 2026-05-31
+98.4%
3-year compound annual growth
+35.4%
5-year compound annual growth
+39.8%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-08-31 | $1.57M | +30.1% | 2025-11-28, Balance as of period end |
| 2024-08-31 | $1.21M | +199.3% | 2025-11-28, Balance as of period end |
| 2023-08-31 | $403.9K | +100.5% | 2024-11-26, Balance as of period end |
| 2022-08-31 | $201.4K | -0.9% | 2023-11-20, Balance as of period end |
| 2021-08-31 | $203.3K | -41.2% | 2022-11-28, Balance as of period end |
| 2020-08-31 | $346.0K | +87.5% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $184.5K | +322.8% | 2020-10-15, Balance as of period end |
| 2018-08-31 | $43.6K | -52.7% | 2019-11-14, Balance as of period end |
| 2017-08-31 | $92.3K | -80.7% | 2018-11-14, Balance as of period end |
| 2016-08-31 | $478.9K | +768.7% | 2017-11-27, Balance as of period end |
| 2015-08-31 | $55.1K | -94.0% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $918.0K | n/a | 2015-11-27, Balance as of period end |
| 2013-10-31 | $1.47M | -16.7% | 2014-01-24, Balance as of period end |
| 2012-10-31 | $1.77M | +5.5% | 2014-01-24, Balance as of period end |
| 2011-10-31 | $1.68M | +49.2% | 2013-01-29, Balance as of period end |
| 2010-10-31 | $1.12M | n/a | 2012-01-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $1.57M | +30.1% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $140.38M | +6.8% |
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $10.70M | -36.1% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $9.16M | -50.7% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $5.08M | -14.4% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $2.40M | -83.8% |
Compare LEXX, PMHS, BTAIQ, HYPD side by side · Screen every company in Pharmaceutical Preparations ↗